DGKA and esophageal squamous cell carcinoma: We further evaluated whether inhibition of DGKα/FAK activity can reduce the secretion of MMPs from ESCC cells; to this end, we treated CCL22-treated KYSE410 and KYSE510 cells with VS-6063 (2.5 μM).